<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-pharmaceutics-12-00688">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shah</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Nair</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Jacob</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Shah</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shehata</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Morsy</surname>
    <given-names>M.A.</given-names>
   </name>
  </person-group>
  <article-title>Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits</article-title>
  <source>Pharmaceutics</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>230</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics11050230</pub-id>
 </element-citation>
</ref>
